| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
With hundreds of thousands devices in the field, Aava Mobile is the world market leader for POS professional tablets and the benchmark in a variety of vertical markets. Aava Mobile partners with the leading POS and Retail OEMs that offer complete table...
Ariane Systems is a Atlanta, GA-based company in the Software and Internet sector.
SMART DOG is one of the leading companies in the Software and Internet sector.
Straive is a market leading Content, Data and e learning/Ed Tech solutions company providing Research & Education content creation services, e learning course design, Data intelligence & operations, unstructured data solutions and platform based techno...